Takayuki Ikezoe
Division of Hematology/Oncology
Cedars-Sinai Medical Center
Los Angeles
USA
Name/email consistency: high
- HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24. Ikezoe, T., Bandobashi, K., Yang, Y., Takeuchi, S., Sekiguchi, N., Sakai, S., Koeffler, H.P., Taguchi, H. Leuk. Res. (2006)
- PC-SPES down-regulates COX-2 via inhibition of NF-kappaB and C/EBPbeta in non-small cell lung cancer cells. Ikezoe, T., Yang, Y., Saitoh, T., Heber, D., McKenna, R., Taguchi, H., Koeffler, H.P. Int. J. Oncol. (2006)
- Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways. Ikezoe, T., Yang, Y., Bandobashi, K., Saito, T., Takemoto, S., Machida, H., Togitani, K., Koeffler, H.P., Taguchi, H. Mol. Cancer Ther. (2005)
- CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. Ikezoe, T., Gery, S., Yin, D., O'Kelly, J., Binderup, L., Lemp, N., Taguchi, H., Koeffler, H.P. Cancer Res. (2005)
- Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells. Ikezoe, T., Yang, Y., Saito, T., Koeffler, H.P., Taguchi, H. Cancer Sci. (2004)
- Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Ikezoe, T., Tanosaki, S., Krug, U., Liu, B., Cohen, P., Taguchi, H., Koeffler, H.P. Blood (2004)
- HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2. Ikezoe, T., Saito, T., Bandobashi, K., Yang, Y., Koeffler, H.P., Taguchi, H. Mol. Cancer Ther. (2004)
- JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA). Ikezoe, T., Yang, Y., Taguchi, H., Koeffler, H.P. Br. J. Cancer (2004)
- Identification of a new GLC1A mutation in a sporadic, primary open-angle glaucoma in Japan. Ikezoe, T., Takeuchit, S., Komatsu, N., Okada, M., Fukushima, A., Ueno, H., Koeffler, H.P., Taguchi, H. Int. J. Mol. Med. (2003)
- Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Ikezoe, T., Chen, S.S., Tong, X.J., Heber, D., Taguchi, H., Koeffler, H.P. Int. J. Oncol. (2003)
- PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells. Ikezoe, T., Chen, S., Saito, T., Asou, H., Kyo, T., Tanosaki, S., Heber, D., Taguchi, H., Koeffler, H.P. Int. J. Oncol. (2003)
- PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells. Ikezoe, T., Chen, S.S., Yang, Y., Heber, D., Taguchi, H., Koeffler, H.P. Int. J. Oncol. (2003)
- PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock. Ikezoe, T., Yang, Y., Heber, D., Taguchi, H., Koeffler, H.P. Mol. Pharmacol. (2003)